meal replacements

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion

March 24, 2025 Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition. The $38 billion U.S. commercial weight loss […]

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion Read More »

GLP-1 Drugs Are Affecting Consumers’ Food Spending Habits

News / John LaRosa

March 5, 2025 Weight loss drugs (GLP-1s) have soared in popularity over the last two years, with about 12% of American adults reporting that they’ve used a medication like Ozempic, Wegovy or Mounjaro to slim down. That’s a big slice of the population — and new research shows that being on these medications influences what

GLP-1 Drugs Are Affecting Consumers’ Food Spending Habits Read More »

Herbalife Reports 2024 Results, $567 Million Weight Loss U.S. Sales

News / John LaRosa

Feb. 2o, 2025 Herbalife reported Q4 and full year 2024 results. The company sells a significant amount of weight loss and meal replacement products each year. “With three consecutive quarters of new distributor growth, a new incoming CEO and significantly improved Adjusted EBITDA2 margins, we enter 2025 with strong momentum.” – Michael Johnson, Chairman and

Herbalife Reports 2024 Results, $567 Million Weight Loss U.S. Sales Read More »

Medifast Reports Q4 and Full Year 2024 Results

News / John LaRosa

Feb. 18, 2025 “This past year was a pivotal year for Medifast, as we continued to transform our business to meet the changing nature of a health and wellness market that has been revolutionized by the rising acceptance of GLP-1 medications,” said Dan Chard, Chairman & CEO. Fourth quarter 2024 revenue decreased 37.7% to $119.0

Medifast Reports Q4 and Full Year 2024 Results Read More »

Weight Loss Market’s Leaders Lost At Least $971 Million in 2023

News / John LaRosa

Sept. 24, 2024 Marketdata LLC, DietBusinessWatch.com’s parent), estimates that the top competitors in the U.S. weight loss market lost at least $971 million in revenues last year, due to the juggernaut of GLP-1 medications. This is a huge transfer of sales from commercial and retail weight loss programs and product segments to medical programs. Here’s

Weight Loss Market’s Leaders Lost At Least $971 Million in 2023 Read More »

U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs

News / John LaRosa

March 4, 2024 U.S. Weight Loss Market Now Worth $90 Billion, Obesity Drug Sales Soar March 4, 2024 Marketdata LLC has just published a new analysis of the weight loss market: “The U.S. Weight Loss Market: 2024 Status Report & Forecast”, March 2024, 107 Pages Some findings: The total U.S. weight loss market is estimated

U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs Read More »

Medifast Reports Q2 Results

News / John LaRosa

Aug. 8, 2023 Second quarter 2023 revenue decreased 34.7% to $296.2 million from $453.3 million for the second quarter of 2022, primarily driven by a decrease in the number of active earning OPTAVIA Coaches and the decline in the productivity per active earning OPTAVIA Coach. The average revenue per active earning OPTAVIA Coach was $5,578, compared to $6,667 for the second quarter last year, a

Medifast Reports Q2 Results Read More »

Weight Loss Market Recovers to $75 Billion – New Marketdata Report

News, Uncategorized / John LaRosa

March 20, 2023 Marketdata LLC, Tampa, FL, has just released it 17th Edition of its best-selling market research report: “The U.S. Weight Loss & Diet Control Market”. At 427 pages, with 160 Tables & Charts and 34 in-depth diet company competitor profiles, this is the most comprehensive analysis anywhere of the market. Some findings… The

Weight Loss Market Recovers to $75 Billion – New Marketdata Report Read More »

Weight Loss Market Rebounds in 2021 From 25% Decline in 2020 – New Report

News, Uncategorized / John LaRosa

March 5, 2022 Marketdata’s new report, The U.S. Weight Loss Market: 2022 Status Report & Forecast (March 2022, 90 pp.) has just been released. Major Findings: The value of the U.S. weight loss market is estimated to have declined by a historic 25% in 2020, to $58 billion. as a result of closures of weight loss centers and

Weight Loss Market Rebounds in 2021 From 25% Decline in 2020 – New Report Read More »

Medifast Posts Strong Q3, Poised to Be #1 Weight Loss Firm

News, Uncategorized / John LaRosa

Nov. 5, 2021 Medifast continued its momentum into the 3rd quarter and is poised to reach 2021 yearly sales of $1.5 billion, topping even Weight Watchers revenue to take over the lead for the first time. This is truly a remarkable feat, in light of the fact that Medifast has never run a national TV

Medifast Posts Strong Q3, Poised to Be #1 Weight Loss Firm Read More »

(813) 971-8080